Header Logo

Connection

JOHN STOUT to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications JOHN STOUT has written about Cost-Benefit Analysis.
JOHN STOUT
Connection Strength
0.031
Cost-Benefit Analysis
  1. Intracameral moxifloxacin for endophthalmitis prophylaxis after cataract surgery: Cost-effectiveness analysis. J Cataract Refract Surg. 2018 Aug; 44(8):971-978.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.